Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Investor in connection with the IPO of Alligator
Mandate

Vinge advised Investor in connection with the IPO of Alligator

November 23, 2016

Alligator Bioscience AB (publ) was listed on the main market of Nasdaq Stockholm with the first day of trading being 23 November 2016. The price in the initial public offering was SEK 32.50 per share, corresponding to a total value of the company’s shares of approx. SEK 2,275 million. Investor AB, through Duba AB, was one of the two selling shareholders.
 
Vinge advised Investor. The Vinge team was headed by capital markets and public M&A partner Erik Sjöman.

Related

Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB

 Vinge has advised Infranity, a private equity firm specializing in infrastructure investments, in connection with its acquisition of a majority stake in Nordic Re-Finance AB, a Scandinavian locomotives lessor. The acquisition brings ambitious development plans for Nordic Re-Finance AB, including expansion into new geographical areas.
January 20, 2025

Vinge advises Platzer in conjunction with the sale of a school property in Gothenburg

 Vinge has advised Platzer Fastigheter AB in connection with the sale of a school property situated in Södra Änggården, Gothenburg. The property, which was sold as a corporate transaction, has a value of SEK 552 million. The sale is part of Platzer's strategy to develop and optimise its property portfolio.
January 17, 2025

Vinge advises Qben Infra in connection with issuance of senior, unsecured bonds and early redemption

 Vinge has advised Qben Infra AB in connection with its issuance of senior, unsecured bonds in an amount of SEK 500,000,000 (within a framework of SEK 600,000,000) and the parallel early redemption by its subsidiary ININ Group AS in respect of its previously issued senior secured bonds due 2027.
January 16, 2025